Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
2
×
acetylon pharmaceuticals
ambys medicines
biontech
biotech
boehringer ingelheim
boston
cell therapy
constellation pharmaceuticals
curevac
eli lilly
gene therapy
genentech
holger willenbring
infectious diseases
ipo
jeffrey tong
john shiver
juan carlos izpisua belmonte
keith dionne
liver disease
markus grompe
martin burke
moderna therapeutics
mrna
national top stories
oregon stem cell center
proteon therapeutics
salk institute for biological studies
san diego blog main
san diego top stories
san francisco
What
deal
2
×
medicines
new
2
×
aiming
ambys
bets
big
bio
biotech
cancer
comes
companies
control
cut
date
deadly
debuted
diseases
effective
enticed
evidence
formed
future
hasn’t
latest
launch
liver
make
messenger
molecules
mrna
multiple
pharmaceutical
primarily
promise
proven
rna
sanofi
second
source
Language
Current search:
deal
×
new
×
" san francisco top stories "
×
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
